Health Sciences Center

Winnipeg, Manitoba R3A 1R9

0 studies enrolling now · 9 studies all time

What they study most

Congestive Heart Failure, Crohn's Disease, HIV Infections, Hypertension, Pulmonary, Infant, Newborn, Influenza A H1N1, Influenza A H3N2, Multiple Sclerosis, Persistent Fetal Circulation Syndrome, Pneumonia, Aspiration, Respiratory Distress Syndrome, Newborn, Respiratory Insufficiency

Studies at this site

• Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A — Completed
• Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease — Completed
• Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008 — Completed
• Inhaled Nitric Oxide Study for Respiratory Failure in Newborns — Stopped early
• A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease — Completed
• Extension Study for 2993-112 — Completed
• Efficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV Patients — Completed
• Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis — Completed
• Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients — Completed